Katsuki et al. recently investigated the use of pitavastatin in a mouse model of AAA and found that it could inhibit AAA formation, being associated with reduced macrophage accumulation, MMP activity and elastin degradation [62]. The gene discussed is ELN; the disease is triple-A syndrome.